Legend
Available Timeslot
Scheduled Appointment
Personal Appointments
Request
Blocked Timeslot
Restricted Timeslot
Search Exhibitors/Products
|
AbbVie |
MR Hall A1402 |
|
|
|
|
|  |  |  |
|
AbbVie |
MR Hall A1502 |
|
|
|
|
| | | |
|
AbbVie |
MR Hall A1602 |
|
|
|
|
| | | |
|
AbbVie |
MR Hall A1403 |
|
|
|
|
| | | |
|
AbbVie |
MR Hall A1503 |
|
|
|
|
| | | |
|
AbbVie |
MR Hall A1603 |
|
|
|
|
| | | |
|
AbbVie |
MR Hall A1404 |
|
|
|
|
| | | |
|
AbbVie |
MR Hall A1504 |
|
|
|
|
| | | |
|
AbbVie |
MR Hall A1604 |
|
|
|
|
| | | |
|
AbbVie |
917 |
|
|
|
|
| | | |
|
Acrotech Biopharma |
2143 |
|
|
|
|
| | | |
|
ADC Therapeutics |
MR Hall A1112 |
|
|
|
|
| | | |
|
ADC Therapeutics |
MR Hall A1212 |
|
|
|
|
| | | |
|
ADC Therapeutics |
736 |
|
|
|
|
| | | |
|
Agios Pharmaceuticals |
1661 |
|
|
|
|
| | | |
|
Agios Pharmaceuticals |
MR Hall A1016 |
|
|
|
|
| | | |
|
Alexion, AstraZeneca Rare Disease |
MR Hall A1001 |
|
|
|
|
| | | |
|
Alexion, AstraZeneca Rare Disease |
MR Hall A1101 |
|
|
|
|
| | | |
|
American Society of Hematology |
1101 |
|
|
|
|
| | | |
|
Apellis Pharmaceuticals |
MR Hall A1214 |
|
|
|
|
| | | |
|
Apellis Pharmaceuticals |
1229 |
|
|
|
|
| | | |
|
Apellis Pharmaceuticals |
1328 |
|
|
|
|
| | | |
|
argenx |
101 |
|
|
|
|
| | | |
|
Arvinas |
171 |
|
|
|
|
| | | |
|
Ascentage Pharma |
2001 |
|
|
|
|
| | | |
|
Astellas Pharma US, Inc. |
2031 |
|
|
|
|
| | | |
|
AstraZeneca |
MR Hall A1201 |
|
|
|
|
| | | |
|
AstraZeneca |
MR Hall A1301 |
|
|
|
|
| | | |
|
AstraZeneca |
MR Hall A1401 |
|
|
|
|
| | | |
|
AstraZeneca |
MR Hall A1501 |
|
|
|
|
| | | |
|
AstraZeneca |
MR Hall A1601 |
|
|
|
|
| | | |
|
AstraZeneca |
MR Hall A1701 |
|
|
|
|
| | | |
|
AstraZeneca |
MR Hall A1801 |
|
|
|
|
| | | |
|
AstraZeneca |
MR Hall A1901 |
|
|
|
|
| | | |
|
AstraZeneca |
MR Hall A2001 |
|
|
|
|
| | | |
|
AstraZeneca |
MR Hall A2101 |
|
|
|
|
| | | |
|
AstraZeneca |
MR Hall A1702 |
|
|
|
|
| | | |
|
AstraZeneca |
MR Hall A1802 |
|
|
|
|
| | | |
|
AstraZeneca |
MR Hall A1902 |
|
|
|
|
| | | |
|
AstraZeneca |
MR Hall A2002 |
|
|
|
|
| | | |
|
AstraZeneca |
MR Hall A2102 |
|
|
|
|
| | | |
|
AstraZeneca |
1343 |
|
|
|
|
| | | |
|
Azurity Pharmaceuticals, Inc |
583 |
|
|
|
|
| | | |
|
Bayer |
2135 |
|
|
|
|
| | | |
|
Beam Therapeutics |
MR Hall A2113 |
|
|
|
|
| | | |
|
Beam Therapeutics |
1963 |
|
|
|
|
| | | |
|
Blueprint Medicines |
881 |
|
|
|
|
| | | |
|
Caribou Biosciences, Inc. |
1173 |
|
|
|
|
| | | |
|
Citius Oncology |
265 |
|
|
|
|
| | | |
|
Cogent Biosciences |
728 |
|
|
|
|
| | | |
|
Conexiant |
154 |
|
|
|
|
| | | |
|
CSL Behring |
1221 |
|
|
|
|
| | | |
|
Daiichi Sankyo |
1235 |
|
|
|
|
| | | |
|
Daiichi Sankyo |
MR Hall A1405 |
|
|
|
|
| | | |
|
Daiichi Sankyo |
MR Hall A1406 |
|
|
|
|
| | | |
|
Eli Lilly and Company |
143 |
|
|
|
|
| | | |
|
Eli Lilly and Company |
MR Hall A2003 |
|
|
|
|
| | | |
|
Eli Lilly and Company |
MR Hall A2103 |
|
|
|
|
| | | |
|
Eli Lilly and Company |
MR Hall A2104 |
|
|
|
|
| | | |
|
Enable Injections |
1081 |
|
|
|
|
| | | |
|
Gamida Cell |
317 |
|
|
|
|
| | | |
|
Genentech |
123 |
|
|
|
|
| | | |
|
Genentech |
MR Hall A1011 |
|
|
|
|
| | | |
|
Genentech |
MR Hall A1012 |
|
|
|
|
| | | |
|
Genentech |
MR Hall A1013 |
|
|
|
|
| | | |
|
Genentech |
MR Hall A1014 |
|
|
|
|
| | | |
|
Gilead and Kite Oncology |
1301 |
|
|
|
|
| | | |
|
Gilead and Kite Oncology |
MR Hall A1309 |
|
|
|
|
| | | |
|
Gilead and Kite Oncology |
MR Hall A1409 |
|
|
|
|
| | | |
|
Gilead and Kite Oncology |
MR Hall A1508 |
|
|
|
|
| | | |
|
Gilead and Kite Oncology |
MR Hall A1609 |
|
|
|
|
| | | |
|
Gilead and Kite Oncology |
MR Hall A1310 |
|
|
|
|
| | | |
|
Gilead and Kite Oncology |
MR Hall A1410 |
|
|
|
|
| | | |
|
Gilead and Kite Oncology |
MR Hall A1509 |
|
|
|
|
| | | |
|
Gilead and Kite Oncology |
MR Hall A1610 |
|
|
|
|
| | | |
|
GSK |
1623 |
|
|
|
|
| | | |
|
GSK |
MR Hall A1015 |
|
|
|
|
| | | |
|
GSK |
MR Hall A1115 |
|
|
|
|
| | | |
|
GSK |
MR Hall A1215 |
|
|
|
|
| | | |
|
GSK |
MR Hall A1315 |
|
|
|
|
| | | |
|
GSK |
MR Hall A1415 |
|
|
|
|
| | | |
|
GSK |
MR Hall A1116 |
|
|
|
|
| | | |
|
GSK |
MR Hall A1216 |
|
|
|
|
| | | |
|
GSK |
MR Hall A1316 |
|
|
|
|
| | | |
|
GSK |
MR Hall A1416 |
|
|
|
|
| | | |
|
Ichnos Glenmark Innovation |
103 |
|
|
|
|
| | | |
|
Ipsen Biopharmaceuticals |
MR Hall A1312 |
|
|
|
|
| | | |
|
Ipsen Biopharmaceuticals |
467 |
|
|
|
|
| | | |
|
Jazz Pharmaceuticals |
1651 |
|
|
|
|
| | | |
|
Jazz Pharmaceuticals |
MR Hall A1110 |
|
|
|
|
| | | |
|
Johnson & Johnson |
1315 |
|
|
|
|
| | | |
|
Johnson & Johnson |
MR Hall A1002 |
|
|
|
|
| | | |
|
Johnson & Johnson |
MR Hall A1102 |
|
|
|
|
| | | |
|
Johnson & Johnson |
MR Hall A1003 |
|
|
|
|
| | | |
|
Johnson & Johnson |
MR Hall A1103 |
|
|
|
|
| | | |
|
Johnson & Johnson |
MR Hall A1004 |
|
|
|
|
| | | |
|
Johnson & Johnson |
MR Hall A1104 |
|
|
|
|
| | | |
|
Johnson & Johnson |
MR Hall A1005 |
|
|
|
|
| | | |
|
Johnson & Johnson |
MR Hall A1105 |
|
|
|
|
| | | |
|
Johnson & Johnson |
MR Hall A1006 |
|
|
|
|
| | | |
|
Johnson & Johnson |
MR Hall A1106 |
|
|
|
|
| | | |
|
Johnson & Johnson |
MR Hall A1107 |
|
|
|
|
| | | |
|
Johnson & Johnson |
MR Hall A1207 |
|
|
|
|
| | | |
|
Karyopharm Therapeutics Inc. |
1743 |
|
|
|
|
| | | |
|
Kura Oncology |
MR Hall A1613 |
|
|
|
|
| | | |
|
Kura Oncology |
601 |
|
|
|
|
| | | |
|
Legend Biotech |
401 |
|
|
|
|
| | | |
|
Mallinckrodt Pharmaceuticals |
1863 |
|
|
|
|
| | | |
|
Melinta Therapeutics |
1381 |
|
|
|
|
| | | |
|
Merck |
MR Hall A1911 |
|
|
|
|
| | | |
|
Merck |
MR Hall A2011 |
|
|
|
|
| | | |
|
Merck |
MR Hall A1912 |
|
|
|
|
| | | |
|
Merck |
MR Hall A2012 |
|
|
|
|
| | | |
|
Merck |
MR Hall A1913 |
|
|
|
|
| | | |
|
Merck |
MR Hall A2013 |
|
|
|
|
| | | |
|
Merck |
MR Hall A2112 |
|
|
|
|
| | | |
|
Merck & Co., Inc. |
201 |
|
|
|
|
| | | |
|
Miltenyi Biomedicine GmbH |
1271 |
|
|
|
|
| | | |
|
Novartis |
642 |
|
|
|
|
| | | |
|
Novartis |
MR Hall A1703 |
|
|
|
|
| | | |
|
Novartis |
MR Hall A1803 |
|
|
|
|
| | | |
|
Novartis |
MR Hall A1903 |
|
|
|
|
| | | |
|
Novartis |
MR Hall A1704 |
|
|
|
|
| | | |
|
Novartis |
MR Hall A1804 |
|
|
|
|
| | | |
|
Novartis |
MR Hall A1904 |
|
|
|
|
| | | |
|
Novo Nordisk Healthcare AG |
1161 |
|
|
|
|
| | | |
|
NURIX |
865 |
|
|
|
|
| | | |
|
ONO PHARMA |
2063 |
|
|
|
|
| | | |
|
ONO PHARMA |
MR Hall A1113 |
|
|
|
|
| | | |
|
Pfizer, Inc. |
MR Hall A2106 |
|
|
|
|
| | | |
|
Pfizer, Inc. |
MR Hall A2107 |
|
|
|
|
| | | |
|
Pfizer, Inc. |
MR Hall A2108 |
|
|
|
|
| | | |
|
Pfizer, Inc. |
MR Hall A2109 |
|
|
|
|
| | | |
|
Pfizer, Inc. |
MR Hall A2110 |
|
|
|
|
| | | |
|
Pfizer, Inc. |
MR Hall A2111 |
|
|
|
|
| | | |
|
Pfizer, Inc. |
1843 |
|
|
|
|
| | | |
|
Protagonist Therapeutics, Inc |
1111 |
|
|
|
|
| | | |
|
Recordati Rare Diseases |
MR Hall A1914 |
|
|
|
|
| | | |
|
Recordati Rare Diseases |
670 |
|
|
|
|
| | | |
|
Recordati Rare Diseases |
672 |
|
|
|
|
| | | |
|
Sanofi |
MR Hall A1605 |
|
|
|
|
| | | |
|
Sanofi |
MR Hall A1705 |
|
|
|
|
| | | |
|
Sanofi |
MR Hall A1805 |
|
|
|
|
| | | |
|
Sanofi |
MR Hall A1905 |
|
|
|
|
| | | |
|
Sanofi |
MR Hall A2005 |
|
|
|
|
| | | |
|
Sanofi |
MR Hall A1505 |
|
|
|
|
| | | |
|
Sanofi |
MR Hall A1606 |
|
|
|
|
| | | |
|
Sanofi |
MR Hall A1706 |
|
|
|
|
| | | |
|
Sanofi |
MR Hall A1806 |
|
|
|
|
| | | |
|
Sanofi |
MR Hall A1906 |
|
|
|
|
| | | |
|
Sanofi |
MR Hall A2006 |
|
|
|
|
| | | |
|
Sanofi |
943 |
|
|
|
|
| | | |
|
Servier Pharmaceuticals |
MR Hall A1313 |
|
|
|
|
| | | |
|
Servier Pharmaceuticals |
MR Hall A1413 |
|
|
|
|
| | | |
|
Servier Pharmaceuticals |
461 |
|
|
|
|
| | | |
|
SOBI, Inc |
1643 |
|
|
|
|
| | | |
|
SOBI, Inc |
MR Hall A2015 |
|
|
|
|
| | | |
|
SOBI, Inc. |
MR Hall A1815 |
|
|
|
|
| | | |
|
SOBI, Inc. |
MR Hall A1915 |
|
|
|
|
| | | |
|
Sophorum Consulting |
685 |
|
|
|
|
| | | |
|
Star Therapeutics |
104 |
|
|
|
|
| | | |
|
Stemline Therapeutics, Inc. |
MR Hall A1007 |
|
|
|
|
| | | |
|
Stemline Therapeutics, Inc. |
1562 |
|
|
|
|
| | | |
|
Sumitomo Pharma America |
1675 |
|
|
|
|
| | | |
|
Taiho Oncology Commercial |
2021 |
|
|
|
|
| | | |
|
Taiho Oncology Commercial |
1609 |
|
|
|
|
| | | |
|
Takeda |
MR Hall A1709 |
|
|
|
|
| | | |
|
Takeda |
MR Hall A1809 |
|
|
|
|
| | | |
|
Takeda |
MR Hall A1710 |
|
|
|
|
| | | |
|
Takeda |
MR Hall A1810 |
|
|
|
|
| | | |
|
Takeda |
MR Hall A1711 |
|
|
|
|
| | | |
|
Takeda |
MR Hall A1811 |
|
|
|
|
| | | |
|
Takeda |
MR Hall A1712 |
|
|
|
|
| | | |
|
Takeda |
MR Hall A1812 |
|
|
|
|
| | | |
|
Takeda |
MR Hall A1713 |
|
|
|
|
| | | |
|
Takeda |
1242 |
|
|
|
|
| | | |
|
Vaniam Group |
775 |
|
|
|
|
| | | |
|
Vertex Pharmaceuticals Inc. |
MR Hall A1210 |
|
|
|
|
| | | |
|
Vertex Pharmaceuticals Inc. |
MR Hall A1211 |
|
|
|
|
| | | |
|
Vertex Pharmaceuticals Inc. |
MR Hall A1311 |
|
|
|
|
| | | |
|
Vertex Pharmaceuticals Inc. |
1831 |
|
|
|
|
| | | |
|
Worldwide Clinical Trials |
160 |
|
|
|
|
| | | |